Advertisement

Medical and Psychosocial Issues in Gynecologic Cancer Survivors

  • Karen Basen-Engquist
  • Diane C. Bodurka

Abstract

An emerging body of research has documented the quality of life of women with gynecologic cancer around the time of diagnosis and during treatment. However, we know much less about the quality of life and psychosocial and medical needs of gynecologic cancer survivors after treatment.1,2 In particular, there are very few studies documenting the risk of possible late medical effects of gynecologic cancer treatment such as osteoporosis and second primary cancers. More is known about self-reported symptoms and psychosocial sequelae, such as sexual functioning and psychologic distress, but even these studies rarely focus on survivors more than 5 years after diagnosis. Additionally, much of the extant research has limitations such as small sample sizes, nonstandardized measures, and cross-sectional designs, often without appropriate comparison groups. Finally, there is a dearth of research testing interventions to ameliorate problems experienced by gynecologic cancer survivors. While in some areas additional research is needed to better describe the sequelae and determine who is at risk for adverse late effects, in others areas (e.g., sexual functioning), adequate data describing the problem are available, and a stronger focus on treatment interventions is needed (see also Chapter 19).

Keywords

Ovarian Cancer Cervical Cancer Cancer Survivor Endometrial Cancer Breast Cancer Survivor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson B, Lutgendorf S. Quality of life in gynecologic cancer survivors. CA Cancer J Clin 1997;47:218–225.PubMedCrossRefGoogle Scholar
  2. 2.
    Auchincloss SS. After treatment: psychosocial issues in gynecologic cancer survivorship. Cancer (Phila) 1995;76(suppl 10):2117–2124.PubMedCrossRefGoogle Scholar
  3. 3.
    Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with stage I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001;19:657–665.PubMedGoogle Scholar
  4. 4.
    Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol 2003;21:1660–1668.PubMedCrossRefGoogle Scholar
  5. 5.
    Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003;21:1653–1659.PubMedCrossRefGoogle Scholar
  6. 6.
    Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531–1543.PubMedGoogle Scholar
  7. 7.
    Goodman MT, Hankin JH, Wilkens LR, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077–5085.PubMedGoogle Scholar
  8. 8.
    Bristow RE. Endometrial cancer. Curr Opin Oncol 1999;11:388–393.PubMedCrossRefGoogle Scholar
  9. 9.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.PubMedCrossRefGoogle Scholar
  10. 10.
    Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2000. Bethesda, MD: National Cancer Institute, 2003.Google Scholar
  11. 11.
    Waggoner SE. Cervical cancer. Lancet 2003;361:2217–2225.PubMedCrossRefGoogle Scholar
  12. 12.
    Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer (Phila) 2000;88:2283–2289.PubMedCrossRefGoogle Scholar
  13. 13.
    Kjaer SK, Engholm G, Dahl C, Bock JE. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: Role of smoking habits. Eur J Cancer Prev 1996;5:359–365.PubMedCrossRefGoogle Scholar
  14. 14.
    Wilkenstein W. Smoking and cervical cancer—current status: a review. J Epidemiol 1990;131:945–957.Google Scholar
  15. 15.
    Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996;5:541–548.PubMedGoogle Scholar
  16. 16.
    Waggoner S, Fuhrman B, Monk B, et al. Influence of smoking on progression-free and overall survival in stage II-B, III-B and IV-A cervical carcinoma: a gynecologic or (GOG) study. Society of Gynecologic Oncologists, New Orleans, LA, January 31 to February 4 2003.Google Scholar
  17. 17.
    Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003;104:669–676.PubMedCrossRefGoogle Scholar
  18. 18.
    Li C, Samsioe G, Iosif C. Quality of life in endometrial cancer survivors. Maturitas 1999;31:227–236.PubMedCrossRefGoogle Scholar
  19. 19.
    Scruggs S, Carmack Taylor C, Jhingran A, et al. Obesity and physical functioning in endometrial cancer survivors. Presented at the Annual Meeting of the Society of Behavioral Medicine, Baltimore, MD, 2004.Google Scholar
  20. 20.
    Li C, Samsioe G, Iosif C. Quality of life in long-term survivors of cervical cancer. Maturitas 1999;32:95–102.PubMedCrossRefGoogle Scholar
  21. 21.
    Klee M, Machin D. Health-related quality of life of patients with endometrial cancer who are disease-free following external irradiation. Acta Oncol 2001;40:816–824.PubMedCrossRefGoogle Scholar
  22. 22.
    Klee M, Thranov I, Machin D. The patients’ perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol 2000;76:14–23.PubMedCrossRefGoogle Scholar
  23. 23.
    Bye A, Trope C, Loge JH, Hjermstad M, Kaasa S. Health-related quality of life occurrence of intestinal side effects after pelvic radiotherapy. Evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000;39:173–180.PubMedCrossRefGoogle Scholar
  24. 24.
    Jereczek-Fossa BA. Postoperative irradiation in endometrial cancer: still a matter of controversy. Cancer Treat Rev 2001;27:19–33.PubMedCrossRefGoogle Scholar
  25. 25.
    DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. St. Louis: Mosby, 2002:675.Google Scholar
  26. 26.
    Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho-Oncology 2002;11:142–153.PubMedCrossRefGoogle Scholar
  27. 27.
    Stewart DE, Wong F, Duff S, Melancon CH, Cheung AM. “What doesn’t kill you makes you stronger”: an ovarian cancer survivor survey. Gynecol Oncol 2001;83:537–542PubMedCrossRefGoogle Scholar
  28. 28.
    Andersen BL, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes. J Consult Clin Psychol 1989;57:683–691.PubMedCrossRefGoogle Scholar
  29. 29.
    Carmack Taylor C, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 2004;22:881–889.PubMedCrossRefGoogle Scholar
  30. 30.
    Headley JA, Theriault RL, LeBlanc AD, Vassilopoulou-Sellin R, Hortobagyi GN. Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. Cancer Invest 1998;16:6–11.PubMedGoogle Scholar
  31. 31.
    Mahon SM, Williams MT, Spies MA. Screening for second cancers and osteoporosis in long-term survivors. Cancer Pract 2000;8:282–290.PubMedCrossRefGoogle Scholar
  32. 32.
    Ersek M, Ferrell BR, Dow KH, Melancon CH. Quality of life in women with ovarian cancer. West J Nurs Res 1997;19:334–350.PubMedCrossRefGoogle Scholar
  33. 33.
    Lutgendorf SK, Anderson B, Ullrich P, et al. Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer (Phila) 2002;94:131–140.PubMedCrossRefGoogle Scholar
  34. 34.
    McCartney CF, Larson DB. Quality of life in patients with gynecologic cancer. Cancer (Phila) 1987;60:2129–2136.PubMedCrossRefGoogle Scholar
  35. 35.
    Andersen BL, Anderson B, deProsse C. Controlled prospective longitudinal study of women with cancer: II. Psychological outcomes. J Consult Clin Psychol 1989;57:692–697.PubMedCrossRefGoogle Scholar
  36. 36.
    Klee M, Thranov I, Machin D. Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol 2000;76:5–13.PubMedCrossRefGoogle Scholar
  37. 37.
    Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E. Prospective assessment of quality of life of female cancer patients. Gynecol Oncol 2002;85:140–147.PubMedCrossRefGoogle Scholar
  38. 38.
    Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000;78:302–308.PubMedCrossRefGoogle Scholar
  39. 39.
    Corney RH, Everett H, Howells A, Crowther ME. Psychosocial adjustment following major gynaecological surgery for carcinoma of the cervix and vulva. J Psychosom Res 1992;36:561–568.PubMedCrossRefGoogle Scholar
  40. 40.
    Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983;62:457.PubMedGoogle Scholar
  41. 41.
    Miller BE, Pittman B, Case D, McQuellon RP. Quality of life after treatment for gynecologic malignacies: A pilot study in an outpatient clinic. Gynecol Oncol 2002;87:178–184.PubMedCrossRefGoogle Scholar
  42. 42.
    Cull A, Cowie VJ, Farquharson DI, Livingstone JR, Smart GE, Elton RA. Early stage cervical cancer: psychosocial and sexual outcomes of treatment. Br J Cancer 1993;68:1216–1220.PubMedGoogle Scholar
  43. 43.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385–401.CrossRefGoogle Scholar
  44. 44.
    Roberts RE, Vernon SW. The center for epidemiologic studies depression scale: its use in a community sample. Am J Psychiatry 1983;140:41–46.PubMedGoogle Scholar
  45. 45.
    Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. State-Trait Anxiety Inventory for Adults: Sampler Set Manual, Test, Scoring Key, vol 1. Palo Alto, CA: Consulting Psychologists Press, 1983:70.Google Scholar
  46. 46.
    Pistrang N, Winchurst C. Gynaecological cancer patients’ attitudes towards psychological services. Psychol Health Med 1997;2:135–147.Google Scholar
  47. 47.
    Paraskevaidis E, Kitchener HC, Walker LG. Doctor-patient communcation and subsequent mental health in women with gynaecological cancer. Psycho-Oncology 1993;2:195–200.CrossRefGoogle Scholar
  48. 48.
    Guidozzi F. Living with ovarian cancer. Gynecol Oncol 1993;50:202–207.PubMedCrossRefGoogle Scholar
  49. 49.
    Basen-Engquist K, Paskett ED, Buzaglo J, et al. Cervical cancer: behavioral factors related to screening, diagnosis, and survivors’ quality of life. Cancer (Suppl) 2003;98:2009–2014.PubMedCrossRefGoogle Scholar
  50. 50.
    Decker WH, Schwartzman E. Sexual function following treatment for carcinoma of the cervix. Am J Obstet Gynecol 1962;83:401–405.PubMedGoogle Scholar
  51. 51.
    Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker N. Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncology 2003;12:267–279.PubMedCrossRefGoogle Scholar
  52. 52.
    Schover LR, Fife M, Gershenson DM. Sexual dysfunction and treatment for early stage cervical cancer. Cancer (Phila) 1989;63:204–212.PubMedCrossRefGoogle Scholar
  53. 53.
    Hartman P, Diddle AW. Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer (Phila) 1972;30:426–429.PubMedCrossRefGoogle Scholar
  54. 54.
    Seibel MM, Freeman MG, Graves WL. Carcinoma of the cervix and sexual function. Obstet Gynecol 1980;55:484–487.PubMedGoogle Scholar
  55. 55.
    Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys 1993;27:825–830.PubMedGoogle Scholar
  56. 56.
    Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340:1383–1389.PubMedCrossRefGoogle Scholar
  57. 57.
    Andersen BL, Turnquist, Dawn, et al. Sexual functioning after treatment of in situ vulvar cancer: preliminary report. Obstet Gynecol 1988;71:15–19.PubMedGoogle Scholar
  58. 58.
    Lamont JA, De Petrillo AD, Sargeant EJ. Psychosexual rehabilitation and exenterative surgery. Gynecol Oncol 1978;6:236–242.PubMedCrossRefGoogle Scholar
  59. 59.
    Capone MA, Good RS, Westie KS, Jacobson AF. Psychosocial rehabilitation of gynecologic oncology patients. Arch Phys Med Rehabil 1980;61:128–132.PubMedGoogle Scholar
  60. 60.
    Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 1999;44:497–506.PubMedCrossRefGoogle Scholar
  61. 61.
    Cain EN, Kohorn EI, Quinlan DM, Latimer K, Schwartz PE. Psychosocial benefits of a cancer support group. Cancer (Phila) 1986;57:183–189.PubMedCrossRefGoogle Scholar
  62. 62.
    Bye A, Kaasa S, Ose T, Sundfor K, Trope C. The influence of low-fat, low lactose diet on radiation induced diarrhoea. Clin Nutr 1992;11:147–153.PubMedCrossRefGoogle Scholar
  63. 63.
    Brekelmans CT. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 2003;15:63–68.PubMedCrossRefGoogle Scholar
  64. 64.
    Gershenson DA, Tortolero-Luna G, Malpica A, et al. Ovarian intraepithelial neoplasia and ovarian cancer. Gynecol Cancer Prev 1996;23:475–543.Google Scholar
  65. 65.
    Edmondson RJ, Monaghan JM. The epidemiology of ovarian cancer. Int J Gynecol Cancer 2001;11:423–429.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Karen Basen-Engquist
    • 1
  • Diane C. Bodurka
    • 2
  1. 1.Department of Behavioral ScienceThe University of Texas at M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of Gynecological OncologyThe University of Texas at M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations